nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—KCNQ3—Amitriptyline—migraine	0.224	0.294	CbGbCtD
Ezogabine—KCNQ2—Amitriptyline—migraine	0.224	0.294	CbGbCtD
Ezogabine—UGT1A4—Valproic Acid—migraine	0.147	0.194	CbGbCtD
Ezogabine—UGT1A3—Valproic Acid—migraine	0.0778	0.102	CbGbCtD
Ezogabine—UGT1A9—Valproic Acid—migraine	0.0594	0.0781	CbGbCtD
Ezogabine—CYP2A6—Valproic Acid—migraine	0.0289	0.038	CbGbCtD
Ezogabine—NAT2—pineal body—migraine	0.00852	0.295	CbGeAlD
Ezogabine—KCNQ5—Potassium Channels—KCNK18—migraine	0.00532	0.0837	CbGpPWpGaD
Ezogabine—KCNQ4—Potassium Channels—KCNK18—migraine	0.00532	0.0837	CbGpPWpGaD
Ezogabine—KCNQ2—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00518	0.0815	CbGpPWpGaD
Ezogabine—KCNQ3—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00518	0.0815	CbGpPWpGaD
Ezogabine—KCNQ2—Interaction between L1 and Ankyrins—SCN2A—migraine	0.0044	0.0693	CbGpPWpGaD
Ezogabine—KCNQ3—Interaction between L1 and Ankyrins—SCN2A—migraine	0.0044	0.0693	CbGpPWpGaD
Ezogabine—KCNQ2—Potassium Channels—KCNK18—migraine	0.00287	0.0452	CbGpPWpGaD
Ezogabine—KCNQ3—Potassium Channels—KCNK18—migraine	0.00287	0.0452	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—KCNK18—migraine	0.00232	0.0365	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—KCNK18—migraine	0.00232	0.0365	CbGpPWpGaD
Ezogabine—KCNQ2—L1CAM interactions—SCN1A—migraine	0.00199	0.0313	CbGpPWpGaD
Ezogabine—KCNQ3—L1CAM interactions—SCN1A—migraine	0.00199	0.0313	CbGpPWpGaD
Ezogabine—KCNQ2—L1CAM interactions—SCN2A—migraine	0.00169	0.0266	CbGpPWpGaD
Ezogabine—KCNQ3—L1CAM interactions—SCN2A—migraine	0.00169	0.0266	CbGpPWpGaD
Ezogabine—KCNQ2—brainstem—migraine	0.00167	0.0578	CbGeAlD
Ezogabine—KCNQ3—cardiovascular system—migraine	0.00148	0.0513	CbGeAlD
Ezogabine—KCNQ4—head—migraine	0.00128	0.0445	CbGeAlD
Ezogabine—KCNQ3—Neuronal System—KCNK18—migraine	0.00125	0.0197	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—KCNK18—migraine	0.00125	0.0197	CbGpPWpGaD
Ezogabine—KCNQ5—head—migraine	0.00125	0.0433	CbGeAlD
Ezogabine—KCNQ5—nervous system—migraine	0.00118	0.041	CbGeAlD
Ezogabine—KCNQ4—cerebellum—migraine	0.00114	0.0397	CbGeAlD
Ezogabine—KCNQ5—central nervous system—migraine	0.00114	0.0395	CbGeAlD
Ezogabine—KCNQ5—Neuronal System—CACNA1A—migraine	0.00113	0.0178	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—CACNA1A—migraine	0.00113	0.0178	CbGpPWpGaD
Ezogabine—KCNQ3—head—migraine	0.001	0.0347	CbGeAlD
Ezogabine—KCNQ3—nervous system—migraine	0.00095	0.0329	CbGeAlD
Ezogabine—KCNQ4—brain—migraine	0.00093	0.0322	CbGeAlD
Ezogabine—KCNQ2—head—migraine	0.000922	0.0319	CbGeAlD
Ezogabine—KCNQ3—central nervous system—migraine	0.000914	0.0317	CbGeAlD
Ezogabine—KCNQ5—brain—migraine	0.000904	0.0313	CbGeAlD
Ezogabine—KCNQ3—cerebellum—migraine	0.000894	0.031	CbGeAlD
Ezogabine—KCNQ2—nervous system—migraine	0.000874	0.0303	CbGeAlD
Ezogabine—KCNQ2—central nervous system—migraine	0.000841	0.0292	CbGeAlD
Ezogabine—KCNQ2—cerebellum—migraine	0.000822	0.0285	CbGeAlD
Ezogabine—KCNQ2—Axon guidance—SCN1A—migraine	0.000751	0.0118	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—SCN1A—migraine	0.000751	0.0118	CbGpPWpGaD
Ezogabine—KCNQ3—brain—migraine	0.000726	0.0252	CbGeAlD
Ezogabine—KCNQ2—brain—migraine	0.000668	0.0232	CbGeAlD
Ezogabine—KCNQ2—Axon guidance—SCN2A—migraine	0.000639	0.0101	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—SCN2A—migraine	0.000639	0.0101	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—CACNA1A—migraine	0.000612	0.00963	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—CACNA1A—migraine	0.000612	0.00963	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—SCN1A—migraine	0.000536	0.00843	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—SCN1A—migraine	0.000536	0.00843	CbGpPWpGaD
Ezogabine—Amnesia—Timolol—migraine	0.000526	0.00358	CcSEcCtD
Ezogabine—Dry mouth—Amitriptyline—migraine	0.000524	0.00357	CcSEcCtD
Ezogabine—Visual impairment—Verapamil—migraine	0.000522	0.00355	CcSEcCtD
Ezogabine—Alopecia—Propranolol—migraine	0.00052	0.00354	CcSEcCtD
Ezogabine—Confusional state—Amitriptyline—migraine	0.000518	0.00353	CcSEcCtD
Ezogabine—Mental disorder—Propranolol—migraine	0.000516	0.00351	CcSEcCtD
Ezogabine—Disorientation—Gabapentin—migraine	0.000514	0.0035	CcSEcCtD
Ezogabine—Shock—Amitriptyline—migraine	0.000505	0.00344	CcSEcCtD
Ezogabine—Thrombocytopenia—Amitriptyline—migraine	0.000503	0.00342	CcSEcCtD
Ezogabine—Hyperhidrosis—Amitriptyline—migraine	0.000496	0.00338	CcSEcCtD
Ezogabine—Osteoarthritis—Timolol—migraine	0.000494	0.00336	CcSEcCtD
Ezogabine—Diplopia—Timolol—migraine	0.000494	0.00336	CcSEcCtD
Ezogabine—Amnesia—Gabapentin—migraine	0.00049	0.00333	CcSEcCtD
Ezogabine—Increased appetite—Gabapentin—migraine	0.00049	0.00333	CcSEcCtD
Ezogabine—Influenza—Valproic Acid—migraine	0.00048	0.00327	CcSEcCtD
Ezogabine—Dysphagia—Valproic Acid—migraine	0.00048	0.00327	CcSEcCtD
Ezogabine—Alopecia—Verapamil—migraine	0.000478	0.00326	CcSEcCtD
Ezogabine—Paraesthesia—Amitriptyline—migraine	0.000461	0.00314	CcSEcCtD
Ezogabine—Vertigo—Propranolol—migraine	0.00046	0.00313	CcSEcCtD
Ezogabine—Osteoarthritis—Gabapentin—migraine	0.00046	0.00313	CcSEcCtD
Ezogabine—Diplopia—Gabapentin—migraine	0.00046	0.00313	CcSEcCtD
Ezogabine—Euphoric mood—Topiramate—migraine	0.000458	0.00312	CcSEcCtD
Ezogabine—Somnolence—Amitriptyline—migraine	0.000457	0.00311	CcSEcCtD
Ezogabine—Liver function test abnormal—Timolol—migraine	0.000456	0.00311	CcSEcCtD
Ezogabine—KCNQ3—Developmental Biology—SCN2A—migraine	0.000456	0.00717	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—SCN2A—migraine	0.000456	0.00717	CbGpPWpGaD
Ezogabine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.000456	0.00717	CbGpPWpGaD
Ezogabine—Muscle spasms—Verapamil—migraine	0.000453	0.00309	CcSEcCtD
Ezogabine—Dyspepsia—Amitriptyline—migraine	0.000452	0.00308	CcSEcCtD
Ezogabine—Psychotic disorder—Gabapentin—migraine	0.000449	0.00306	CcSEcCtD
Ezogabine—Dysuria—Valproic Acid—migraine	0.000448	0.00305	CcSEcCtD
Ezogabine—Neutropenia—Valproic Acid—migraine	0.000448	0.00305	CcSEcCtD
Ezogabine—Vision blurred—Verapamil—migraine	0.000444	0.00302	CcSEcCtD
Ezogabine—Fatigue—Amitriptyline—migraine	0.000443	0.00302	CcSEcCtD
Ezogabine—Tremor—Verapamil—migraine	0.000442	0.00301	CcSEcCtD
Ezogabine—Constipation—Amitriptyline—migraine	0.000439	0.00299	CcSEcCtD
Ezogabine—Urinary retention—Gabapentin—migraine	0.000437	0.00298	CcSEcCtD
Ezogabine—Weight increased—Valproic Acid—migraine	0.000436	0.00297	CcSEcCtD
Ezogabine—Disorientation—Topiramate—migraine	0.000433	0.00295	CcSEcCtD
Ezogabine—Liver function test abnormal—Gabapentin—migraine	0.000425	0.00289	CcSEcCtD
Ezogabine—Vertigo—Verapamil—migraine	0.000423	0.00288	CcSEcCtD
Ezogabine—Feeling abnormal—Amitriptyline—migraine	0.000423	0.00288	CcSEcCtD
Ezogabine—Syncope—Verapamil—migraine	0.000423	0.00288	CcSEcCtD
Ezogabine—KCNQ2—Developmental Biology—MEF2D—migraine	0.000417	0.00656	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MEF2D—migraine	0.000417	0.00656	CbGpPWpGaD
Ezogabine—Infection—Propranolol—migraine	0.000415	0.00283	CcSEcCtD
Ezogabine—Loss of consciousness—Verapamil—migraine	0.000414	0.00282	CcSEcCtD
Ezogabine—Amnesia—Topiramate—migraine	0.000412	0.00281	CcSEcCtD
Ezogabine—Increased appetite—Topiramate—migraine	0.000412	0.00281	CcSEcCtD
Ezogabine—Nervous system disorder—Propranolol—migraine	0.00041	0.00279	CcSEcCtD
Ezogabine—CYP2A6—cerebellum—migraine	0.000409	0.0142	CbGeAlD
Ezogabine—Hepatobiliary disease—Valproic Acid—migraine	0.000404	0.00275	CcSEcCtD
Ezogabine—Dysuria—Timolol—migraine	0.000399	0.00272	CcSEcCtD
Ezogabine—Influenza—Gabapentin—migraine	0.000398	0.00271	CcSEcCtD
Ezogabine—Dysphagia—Gabapentin—migraine	0.000398	0.00271	CcSEcCtD
Ezogabine—Discomfort—Verapamil—migraine	0.000396	0.0027	CcSEcCtD
Ezogabine—Dry mouth—Verapamil—migraine	0.000392	0.00267	CcSEcCtD
Ezogabine—Confusional state—Verapamil—migraine	0.000388	0.00264	CcSEcCtD
Ezogabine—Diplopia—Topiramate—migraine	0.000387	0.00264	CcSEcCtD
Ezogabine—Osteoarthritis—Topiramate—migraine	0.000387	0.00264	CcSEcCtD
Ezogabine—Infection—Verapamil—migraine	0.000382	0.0026	CcSEcCtD
Ezogabine—Hallucination—Valproic Acid—migraine	0.000382	0.0026	CcSEcCtD
Ezogabine—Urinary tract disorder—Valproic Acid—migraine	0.000379	0.00258	CcSEcCtD
Ezogabine—Shock—Verapamil—migraine	0.000378	0.00258	CcSEcCtD
Ezogabine—Oedema peripheral—Valproic Acid—migraine	0.000378	0.00258	CcSEcCtD
Ezogabine—Psychotic disorder—Topiramate—migraine	0.000378	0.00257	CcSEcCtD
Ezogabine—Urethral disorder—Valproic Acid—migraine	0.000376	0.00256	CcSEcCtD
Ezogabine—Paraesthesia—Propranolol—migraine	0.000375	0.00256	CcSEcCtD
Ezogabine—Dyspnoea—Propranolol—migraine	0.000373	0.00254	CcSEcCtD
Ezogabine—Hyperhidrosis—Verapamil—migraine	0.000372	0.00253	CcSEcCtD
Ezogabine—Dysuria—Gabapentin—migraine	0.000372	0.00253	CcSEcCtD
Ezogabine—Somnolence—Propranolol—migraine	0.000372	0.00253	CcSEcCtD
Ezogabine—Visual impairment—Valproic Acid—migraine	0.00037	0.00252	CcSEcCtD
Ezogabine—Asthenia—Amitriptyline—migraine	0.000368	0.00251	CcSEcCtD
Ezogabine—Dyspepsia—Propranolol—migraine	0.000368	0.00251	CcSEcCtD
Ezogabine—Urinary retention—Topiramate—migraine	0.000368	0.00251	CcSEcCtD
Ezogabine—Weight increased—Gabapentin—migraine	0.000362	0.00246	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Propranolol—migraine	0.000361	0.00246	CcSEcCtD
Ezogabine—Fatigue—Propranolol—migraine	0.00036	0.00246	CcSEcCtD
Ezogabine—Eye disorder—Valproic Acid—migraine	0.000359	0.00244	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—SLC6A4—migraine	0.000358	0.00563	CbGpPWpGaD
Ezogabine—Constipation—Propranolol—migraine	0.000358	0.00244	CcSEcCtD
Ezogabine—Liver function test abnormal—Topiramate—migraine	0.000357	0.00243	CcSEcCtD
Ezogabine—Infestation NOS—Gabapentin—migraine	0.000354	0.00241	CcSEcCtD
Ezogabine—Infestation—Gabapentin—migraine	0.000354	0.00241	CcSEcCtD
Ezogabine—Paraesthesia—Verapamil—migraine	0.000345	0.00235	CcSEcCtD
Ezogabine—Dyspnoea—Verapamil—migraine	0.000343	0.00234	CcSEcCtD
Ezogabine—Somnolence—Verapamil—migraine	0.000342	0.00233	CcSEcCtD
Ezogabine—Hallucination—Timolol—migraine	0.00034	0.00232	CcSEcCtD
Ezogabine—Dizziness—Amitriptyline—migraine	0.00034	0.00231	CcSEcCtD
Ezogabine—Alopecia—Valproic Acid—migraine	0.000339	0.00231	CcSEcCtD
Ezogabine—Dyspepsia—Verapamil—migraine	0.000339	0.00231	CcSEcCtD
Ezogabine—Haematuria—Gabapentin—migraine	0.000338	0.0023	CcSEcCtD
Ezogabine—Oedema peripheral—Timolol—migraine	0.000337	0.00229	CcSEcCtD
Ezogabine—Mental disorder—Valproic Acid—migraine	0.000336	0.00229	CcSEcCtD
Ezogabine—Hepatobiliary disease—Gabapentin—migraine	0.000335	0.00228	CcSEcCtD
Ezogabine—Dysphagia—Topiramate—migraine	0.000334	0.00228	CcSEcCtD
Ezogabine—Malnutrition—Valproic Acid—migraine	0.000334	0.00228	CcSEcCtD
Ezogabine—CYP2A6—brain—migraine	0.000332	0.0115	CbGeAlD
Ezogabine—Fatigue—Verapamil—migraine	0.000332	0.00226	CcSEcCtD
Ezogabine—Visual impairment—Timolol—migraine	0.000329	0.00224	CcSEcCtD
Ezogabine—Constipation—Verapamil—migraine	0.000329	0.00224	CcSEcCtD
Ezogabine—Rash—Amitriptyline—migraine	0.000324	0.00221	CcSEcCtD
Ezogabine—Dermatitis—Amitriptyline—migraine	0.000323	0.0022	CcSEcCtD
Ezogabine—Muscle spasms—Valproic Acid—migraine	0.000321	0.00219	CcSEcCtD
Ezogabine—Eye disorder—Timolol—migraine	0.000319	0.00217	CcSEcCtD
Ezogabine—CYP2A6—Fluoropyrimidine Activity—MTHFR—migraine	0.000319	0.00501	CbGpPWpGaD
Ezogabine—Feeling abnormal—Verapamil—migraine	0.000317	0.00216	CcSEcCtD
Ezogabine—Hallucination—Gabapentin—migraine	0.000317	0.00216	CcSEcCtD
Ezogabine—Vision blurred—Valproic Acid—migraine	0.000315	0.00214	CcSEcCtD
Ezogabine—Urinary tract disorder—Gabapentin—migraine	0.000314	0.00214	CcSEcCtD
Ezogabine—Oedema peripheral—Gabapentin—migraine	0.000313	0.00213	CcSEcCtD
Ezogabine—Tremor—Valproic Acid—migraine	0.000313	0.00213	CcSEcCtD
Ezogabine—Dysuria—Topiramate—migraine	0.000313	0.00213	CcSEcCtD
Ezogabine—Neutropenia—Topiramate—migraine	0.000313	0.00213	CcSEcCtD
Ezogabine—Urethral disorder—Gabapentin—migraine	0.000312	0.00212	CcSEcCtD
Ezogabine—Ill-defined disorder—Valproic Acid—migraine	0.00031	0.00211	CcSEcCtD
Ezogabine—Visual impairment—Gabapentin—migraine	0.000307	0.00209	CcSEcCtD
Ezogabine—Nausea—Amitriptyline—migraine	0.000305	0.00208	CcSEcCtD
Ezogabine—Weight increased—Topiramate—migraine	0.000304	0.00207	CcSEcCtD
Ezogabine—Alopecia—Timolol—migraine	0.000302	0.00206	CcSEcCtD
Ezogabine—Malaise—Valproic Acid—migraine	0.000301	0.00205	CcSEcCtD
Ezogabine—Vertigo—Valproic Acid—migraine	0.0003	0.00204	CcSEcCtD
Ezogabine—Asthenia—Propranolol—migraine	0.0003	0.00204	CcSEcCtD
Ezogabine—Mental disorder—Timolol—migraine	0.000299	0.00204	CcSEcCtD
Ezogabine—Leukopenia—Valproic Acid—migraine	0.000299	0.00204	CcSEcCtD
Ezogabine—Infestation NOS—Topiramate—migraine	0.000298	0.00203	CcSEcCtD
Ezogabine—Infestation—Topiramate—migraine	0.000298	0.00203	CcSEcCtD
Ezogabine—Malnutrition—Timolol—migraine	0.000297	0.00203	CcSEcCtD
Ezogabine—Eye disorder—Gabapentin—migraine	0.000297	0.00203	CcSEcCtD
Ezogabine—UGT1A3—NRF2 pathway—SLC6A4—migraine	0.000297	0.00468	CbGpPWpGaD
Ezogabine—Haematuria—Topiramate—migraine	0.000284	0.00194	CcSEcCtD
Ezogabine—Anxiety—Valproic Acid—migraine	0.000284	0.00193	CcSEcCtD
Ezogabine—Alopecia—Gabapentin—migraine	0.000281	0.00192	CcSEcCtD
Ezogabine—Discomfort—Valproic Acid—migraine	0.000281	0.00191	CcSEcCtD
Ezogabine—Vision blurred—Timolol—migraine	0.00028	0.00191	CcSEcCtD
Ezogabine—Mental disorder—Gabapentin—migraine	0.000279	0.0019	CcSEcCtD
Ezogabine—Dry mouth—Valproic Acid—migraine	0.000278	0.00189	CcSEcCtD
Ezogabine—Malnutrition—Gabapentin—migraine	0.000277	0.00189	CcSEcCtD
Ezogabine—Dizziness—Propranolol—migraine	0.000277	0.00188	CcSEcCtD
Ezogabine—Asthenia—Verapamil—migraine	0.000276	0.00188	CcSEcCtD
Ezogabine—Confusional state—Valproic Acid—migraine	0.000275	0.00187	CcSEcCtD
Ezogabine—Infection—Valproic Acid—migraine	0.000271	0.00185	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—TGFBR2—migraine	0.00027	0.00424	CbGpPWpGaD
Ezogabine—Nervous system disorder—Valproic Acid—migraine	0.000267	0.00182	CcSEcCtD
Ezogabine—Vertigo—Timolol—migraine	0.000267	0.00182	CcSEcCtD
Ezogabine—Thrombocytopenia—Valproic Acid—migraine	0.000267	0.00182	CcSEcCtD
Ezogabine—Syncope—Timolol—migraine	0.000267	0.00182	CcSEcCtD
Ezogabine—Hallucination—Topiramate—migraine	0.000266	0.00181	CcSEcCtD
Ezogabine—Muscle spasms—Gabapentin—migraine	0.000266	0.00181	CcSEcCtD
Ezogabine—Urinary tract disorder—Topiramate—migraine	0.000264	0.0018	CcSEcCtD
Ezogabine—Oedema peripheral—Topiramate—migraine	0.000264	0.0018	CcSEcCtD
Ezogabine—Hyperhidrosis—Valproic Acid—migraine	0.000264	0.0018	CcSEcCtD
Ezogabine—Rash—Propranolol—migraine	0.000264	0.0018	CcSEcCtD
Ezogabine—Dermatitis—Propranolol—migraine	0.000263	0.00179	CcSEcCtD
Ezogabine—Urethral disorder—Topiramate—migraine	0.000262	0.00179	CcSEcCtD
Ezogabine—Loss of consciousness—Timolol—migraine	0.000261	0.00178	CcSEcCtD
Ezogabine—Vision blurred—Gabapentin—migraine	0.000261	0.00178	CcSEcCtD
Ezogabine—Tremor—Gabapentin—migraine	0.00026	0.00177	CcSEcCtD
Ezogabine—Visual impairment—Topiramate—migraine	0.000258	0.00176	CcSEcCtD
Ezogabine—Ill-defined disorder—Gabapentin—migraine	0.000257	0.00175	CcSEcCtD
Ezogabine—Dizziness—Verapamil—migraine	0.000254	0.00173	CcSEcCtD
Ezogabine—Anxiety—Timolol—migraine	0.000252	0.00172	CcSEcCtD
Ezogabine—Discomfort—Timolol—migraine	0.00025	0.0017	CcSEcCtD
Ezogabine—Eye disorder—Topiramate—migraine	0.00025	0.0017	CcSEcCtD
Ezogabine—Malaise—Gabapentin—migraine	0.00025	0.0017	CcSEcCtD
Ezogabine—Vertigo—Gabapentin—migraine	0.000249	0.00169	CcSEcCtD
Ezogabine—Syncope—Gabapentin—migraine	0.000248	0.00169	CcSEcCtD
Ezogabine—Nausea—Propranolol—migraine	0.000248	0.00169	CcSEcCtD
Ezogabine—Leukopenia—Gabapentin—migraine	0.000248	0.00169	CcSEcCtD
Ezogabine—Dry mouth—Timolol—migraine	0.000248	0.00169	CcSEcCtD
Ezogabine—Paraesthesia—Valproic Acid—migraine	0.000245	0.00167	CcSEcCtD
Ezogabine—Confusional state—Timolol—migraine	0.000245	0.00167	CcSEcCtD
Ezogabine—Loss of consciousness—Gabapentin—migraine	0.000243	0.00166	CcSEcCtD
Ezogabine—Dyspnoea—Valproic Acid—migraine	0.000243	0.00166	CcSEcCtD
Ezogabine—Rash—Verapamil—migraine	0.000243	0.00165	CcSEcCtD
Ezogabine—Somnolence—Valproic Acid—migraine	0.000242	0.00165	CcSEcCtD
Ezogabine—Dermatitis—Verapamil—migraine	0.000242	0.00165	CcSEcCtD
Ezogabine—Infection—Timolol—migraine	0.000241	0.00164	CcSEcCtD
Ezogabine—Dyspepsia—Valproic Acid—migraine	0.00024	0.00163	CcSEcCtD
Ezogabine—Shock—Timolol—migraine	0.000239	0.00163	CcSEcCtD
Ezogabine—Nervous system disorder—Timolol—migraine	0.000238	0.00162	CcSEcCtD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000238	0.00374	CbGpPWpGaD
Ezogabine—Alopecia—Topiramate—migraine	0.000237	0.00161	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Valproic Acid—migraine	0.000235	0.0016	CcSEcCtD
Ezogabine—Fatigue—Valproic Acid—migraine	0.000235	0.0016	CcSEcCtD
Ezogabine—Anxiety—Gabapentin—migraine	0.000235	0.0016	CcSEcCtD
Ezogabine—Hyperhidrosis—Timolol—migraine	0.000235	0.0016	CcSEcCtD
Ezogabine—Mental disorder—Topiramate—migraine	0.000235	0.0016	CcSEcCtD
Ezogabine—Constipation—Valproic Acid—migraine	0.000233	0.00159	CcSEcCtD
Ezogabine—Malnutrition—Topiramate—migraine	0.000233	0.00159	CcSEcCtD
Ezogabine—Discomfort—Gabapentin—migraine	0.000233	0.00159	CcSEcCtD
Ezogabine—Dry mouth—Gabapentin—migraine	0.000231	0.00157	CcSEcCtD
Ezogabine—Nausea—Verapamil—migraine	0.000228	0.00156	CcSEcCtD
Ezogabine—Confusional state—Gabapentin—migraine	0.000228	0.00155	CcSEcCtD
Ezogabine—Feeling abnormal—Valproic Acid—migraine	0.000225	0.00153	CcSEcCtD
Ezogabine—Infection—Gabapentin—migraine	0.000225	0.00153	CcSEcCtD
Ezogabine—UGT1A3—NRF2 pathway—TGFBR2—migraine	0.000224	0.00353	CbGpPWpGaD
Ezogabine—Muscle spasms—Topiramate—migraine	0.000224	0.00153	CcSEcCtD
Ezogabine—Shock—Gabapentin—migraine	0.000222	0.00151	CcSEcCtD
Ezogabine—Nervous system disorder—Gabapentin—migraine	0.000222	0.00151	CcSEcCtD
Ezogabine—Thrombocytopenia—Gabapentin—migraine	0.000221	0.00151	CcSEcCtD
Ezogabine—Vision blurred—Topiramate—migraine	0.00022	0.0015	CcSEcCtD
Ezogabine—Hyperhidrosis—Gabapentin—migraine	0.000219	0.00149	CcSEcCtD
Ezogabine—Tremor—Topiramate—migraine	0.000218	0.00149	CcSEcCtD
Ezogabine—Paraesthesia—Timolol—migraine	0.000218	0.00148	CcSEcCtD
Ezogabine—Dyspnoea—Timolol—migraine	0.000216	0.00147	CcSEcCtD
Ezogabine—Ill-defined disorder—Topiramate—migraine	0.000216	0.00147	CcSEcCtD
Ezogabine—Somnolence—Timolol—migraine	0.000216	0.00147	CcSEcCtD
Ezogabine—Dyspepsia—Timolol—migraine	0.000214	0.00146	CcSEcCtD
Ezogabine—Malaise—Topiramate—migraine	0.00021	0.00143	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Timolol—migraine	0.00021	0.00143	CcSEcCtD
Ezogabine—Vertigo—Topiramate—migraine	0.000209	0.00143	CcSEcCtD
Ezogabine—Fatigue—Timolol—migraine	0.000209	0.00143	CcSEcCtD
Ezogabine—Syncope—Topiramate—migraine	0.000209	0.00142	CcSEcCtD
Ezogabine—Leukopenia—Topiramate—migraine	0.000209	0.00142	CcSEcCtD
Ezogabine—UGT1A1—NRF2 pathway—SLC6A4—migraine	0.000205	0.00323	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—SLC6A4—migraine	0.000205	0.00323	CbGpPWpGaD
Ezogabine—Loss of consciousness—Topiramate—migraine	0.000205	0.0014	CcSEcCtD
Ezogabine—Paraesthesia—Gabapentin—migraine	0.000203	0.00138	CcSEcCtD
Ezogabine—Dyspnoea—Gabapentin—migraine	0.000202	0.00137	CcSEcCtD
Ezogabine—Somnolence—Gabapentin—migraine	0.000201	0.00137	CcSEcCtD
Ezogabine—Feeling abnormal—Timolol—migraine	0.0002	0.00136	CcSEcCtD
Ezogabine—Dyspepsia—Gabapentin—migraine	0.000199	0.00136	CcSEcCtD
Ezogabine—Anxiety—Topiramate—migraine	0.000198	0.00135	CcSEcCtD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000198	0.00311	CbGpPWpGaD
Ezogabine—Discomfort—Topiramate—migraine	0.000196	0.00134	CcSEcCtD
Ezogabine—Asthenia—Valproic Acid—migraine	0.000196	0.00133	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Gabapentin—migraine	0.000195	0.00133	CcSEcCtD
Ezogabine—Fatigue—Gabapentin—migraine	0.000195	0.00133	CcSEcCtD
Ezogabine—Dry mouth—Topiramate—migraine	0.000194	0.00132	CcSEcCtD
Ezogabine—Constipation—Gabapentin—migraine	0.000193	0.00132	CcSEcCtD
Ezogabine—Confusional state—Topiramate—migraine	0.000192	0.00131	CcSEcCtD
Ezogabine—Infection—Topiramate—migraine	0.000189	0.00129	CcSEcCtD
Ezogabine—Shock—Topiramate—migraine	0.000187	0.00127	CcSEcCtD
Ezogabine—Nervous system disorder—Topiramate—migraine	0.000187	0.00127	CcSEcCtD
Ezogabine—Feeling abnormal—Gabapentin—migraine	0.000186	0.00127	CcSEcCtD
Ezogabine—Thrombocytopenia—Topiramate—migraine	0.000186	0.00127	CcSEcCtD
Ezogabine—Hyperhidrosis—Topiramate—migraine	0.000184	0.00125	CcSEcCtD
Ezogabine—Dizziness—Valproic Acid—migraine	0.00018	0.00123	CcSEcCtD
Ezogabine—Asthenia—Timolol—migraine	0.000174	0.00119	CcSEcCtD
Ezogabine—Rash—Valproic Acid—migraine	0.000172	0.00117	CcSEcCtD
Ezogabine—Dermatitis—Valproic Acid—migraine	0.000172	0.00117	CcSEcCtD
Ezogabine—Paraesthesia—Topiramate—migraine	0.000171	0.00116	CcSEcCtD
Ezogabine—Dyspnoea—Topiramate—migraine	0.00017	0.00115	CcSEcCtD
Ezogabine—Somnolence—Topiramate—migraine	0.000169	0.00115	CcSEcCtD
Ezogabine—Dyspepsia—Topiramate—migraine	0.000167	0.00114	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Topiramate—migraine	0.000164	0.00112	CcSEcCtD
Ezogabine—Fatigue—Topiramate—migraine	0.000164	0.00112	CcSEcCtD
Ezogabine—NAT2—Metabolism—CACNA1A—migraine	0.000164	0.00258	CbGpPWpGaD
Ezogabine—Constipation—Topiramate—migraine	0.000163	0.00111	CcSEcCtD
Ezogabine—Asthenia—Gabapentin—migraine	0.000162	0.0011	CcSEcCtD
Ezogabine—Nausea—Valproic Acid—migraine	0.000162	0.0011	CcSEcCtD
Ezogabine—Dizziness—Timolol—migraine	0.000161	0.00109	CcSEcCtD
Ezogabine—CYP2A6—NRF2 pathway—SLC6A4—migraine	0.000158	0.00249	CbGpPWpGaD
Ezogabine—Feeling abnormal—Topiramate—migraine	0.000157	0.00107	CcSEcCtD
Ezogabine—UGT1A9—NRF2 pathway—TGFBR2—migraine	0.000155	0.00244	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—TGFBR2—migraine	0.000155	0.00244	CbGpPWpGaD
Ezogabine—Rash—Timolol—migraine	0.000153	0.00104	CcSEcCtD
Ezogabine—Dermatitis—Timolol—migraine	0.000153	0.00104	CcSEcCtD
Ezogabine—Dizziness—Gabapentin—migraine	0.00015	0.00102	CcSEcCtD
Ezogabine—Nausea—Timolol—migraine	0.000144	0.000982	CcSEcCtD
Ezogabine—Rash—Gabapentin—migraine	0.000143	0.000971	CcSEcCtD
Ezogabine—Dermatitis—Gabapentin—migraine	0.000142	0.00097	CcSEcCtD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000137	0.00215	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000137	0.00215	CbGpPWpGaD
Ezogabine—Asthenia—Topiramate—migraine	0.000136	0.000929	CcSEcCtD
Ezogabine—Nausea—Gabapentin—migraine	0.000134	0.000915	CcSEcCtD
Ezogabine—Dizziness—Topiramate—migraine	0.000126	0.000857	CcSEcCtD
Ezogabine—Rash—Topiramate—migraine	0.00012	0.000817	CcSEcCtD
Ezogabine—Dermatitis—Topiramate—migraine	0.00012	0.000816	CcSEcCtD
Ezogabine—CYP2A6—NRF2 pathway—TGFBR2—migraine	0.000119	0.00188	CbGpPWpGaD
Ezogabine—Nausea—Topiramate—migraine	0.000113	0.000769	CcSEcCtD
Ezogabine—UGT1A4—Metabolism—CACNA1A—migraine	9.93e-05	0.00156	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CACNA1A—migraine	8.26e-05	0.0013	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CACNA1A—migraine	5.71e-05	0.000898	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CACNA1A—migraine	5.71e-05	0.000898	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TNF—migraine	5.52e-05	0.000869	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TNF—migraine	5.52e-05	0.000869	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MTHFR—migraine	5.42e-05	0.000853	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CACNA1A—migraine	4.4e-05	0.000692	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MTHFR—migraine	3.29e-05	0.000517	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MTHFR—migraine	2.73e-05	0.00043	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTHFR—migraine	1.89e-05	0.000297	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTHFR—migraine	1.89e-05	0.000297	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTHFR—migraine	1.45e-05	0.000229	CbGpPWpGaD
